Gaudium IVF IPO GMP Remains Steady On Day 2 Of Subscription

The Gaudium IVF initial public offering (IPO) has shown stability in its grey market premium (GMP) on the second day of subscription. As investors continue to evaluate the offering, the listing date for Gaudium IVF is tentatively scheduled for February 27. The response from the market so far indicates a sustained interest in the company, which specializes in fertility treatments and related services. The IPO is part of a broader trend in India where healthcare-focused companies are increasingly turning to public markets to raise capital for expansion and innovation. Investors are keenly analyzing the potential of Gaudium IVF, which aims to capitalize on the growing demand for assisted reproductive technologies in the country. As the subscription period progresses, market watchers will be closely monitoring the GMP and overall investor sentiment leading up to the listing date.